Tag: RAPIDAI
Rapid ICH receives new US FDA clearance with “highest sensitivity and...
RapidAI has announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for the latest release of Rapid ICH—a technology that it describes as...
RAPID Aneurysm programme shows positive early performance in retrospective study
RAPID Aneurysm, a semi-automated artificial intelligence (AI) software programme (RapidAI), is highly accurate in detecting cerebral aneurysms on computed tomography angiography (CTA) imaging, according...
RapidAI receives US FDA clearance for Rapid Hyperdensity
RapidAI has announced receipt of US Food and Drug Administration (FDA) clearance for Rapid Hyperdensity—the newest addition to the RapidAI platform. According to the company,...
RapidAI announces Karim Karti as new CEO
RapidAI has announced Karim Karti, former president and CEO of GE Healthcare Imaging, as the company’s chief executive officer (CEO).
“Karim’s tremendous global experience in...
RapidAI unveils prehospital solution to optimise cross-team workflow and improve patient...
RapidAI has announced the launch of its Rapid prehospital workflow solution for stroke, which optimises coordination between emergency medical services (EMS) providers and hospital...
RapidAI experiences nearly 300% growth
RapidAI, a neuroimaging stroke software platform which uses artificial intelligence (AI), has announced growth of nearly 300%. This has been attributed by RapidAI in...
RapidAI announces software approval for Medicare New Technology Add-on Payment
RapidAI states Rapid LVO is among the first software products to qualify for the New Technology Add-on Payment (NTAP).
NTAP is part of the CMS...
